Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10568874 Indane-amines as PD-L1 antagonists

Patent 10568874 was granted and assigned to ChemoCentryx on February, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

ChemoCentryx

Current Assignee

ChemoCentryx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10568874

Patent Inventor Names

Christopher Lange0

Rajinder Singh0

Sreenivas Punna0

Ju Yang0

Penglie Zhang0

Date of Patent

February 25, 2020

Patent Application Number

16281448

Date Filed

February 21, 2019

Patent Citations Received

‌

US Patent 12083118 Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same

‌

US Patent 11059834 Macrocyclic immunomodulators

‌

US Patent 11691985 Macrocyclic immunomodulators

‌

US Patent 11708326 Immunomodulator compounds

‌

US Patent 11759458 Indane-amines as PD-L1 antagonists

‌

US Patent 11426364 Immunomodulator compounds

‌

US Patent 11866429 Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases

‌

US Patent 11872217 Indanes as PD-L1 inhibitors

Patent Primary Examiner

‌

D Margaret M Seaman

Patent abstract

Compounds are provided that are useful as immunomodulators. The compounds have the Formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10568874 Indane-amines as PD-L1 antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API